Founded in 2010, Abionic SA is uniquely positioned at the intersection of medical technology, biotechnology and nanotechnology. Abionic developed its nanotechnology within the Swiss Federal Institute of Technology in Lausanne (EPFL) and now provides the medical community with a new generation of products, which allows a fast and personalized diagnosis.
Abionic is committed to improve the world of medical diagnosis by providing healthcare providers with a rapid diagnostic platform based on a revolutionary nanotechnology.
Abionic is a Swiss company active in the development of medical products. The company has developed a revolutionary nanotechnology, which offers medical professionals new rapid diagnostic tools that enable them to measure their patients’ allergy profiles, in record time… Abionic brings nanotechnology to the medical office, to the benefit of the patient.